A sustained drop in body mass index during midlife is associated with a 19% reduction in all-cause mortality over a 35-year ...

A one-off weight-loss treatment that has been around since the 1950s is far superior than drugs like Ozempic when it comes to ...

The NHS says Tirzepatide, also called Mounjaro, is a weekly injection that patients do themselves, making them feel fuller ...

Dr. David A. Kessler tested GLP-1 drugs to shed some pounds over seven months and found there was one rather uncomfortable ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

Part of the appeal of amylin analogs is the potential to drive weight loss without causing the same level of tolerability problems as GLP-1 receptor agonists. Lilly reported relatively low rates of ...

Sarah Hill, 32, from Glasgow, had struggled with her weight since her late teens - but everything changed after using a jab ...

A mother of two, who previously cancelled nights out because she felt like "the overweight one," has shed two stone in just ...

A mother of two, who previously cancelled nights out because she felt like "the overweight one," has shed two stone in just ...

Eli Lilly's (LLY) experimental obesity drug, eloralintide, shows up to 11% weight loss in 12 weeks with minimal side effects in early-stage trial. Read more here.

Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...

Weight-loss injections are the new quick fix. But a silent risk is catching women off guard – with life-changing consequences ...